A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium

Autor: Laurie, Scott A., Goss, Glenwood D., Shepherd, Frances A., Reaume, M. Neil, Nicholas, Garth, Philip, Lindsay, Wang, Lisa, Schwock, Joerg, Hirsh, Vera, Oza, Amit, Tsao, Ming-Sound, Wright, John J., Leighl, Natasha B.
Zdroj: In Clinical Lung Cancer January 2014 15(1):52-57
Databáze: ScienceDirect